Fourth Quarter 2025 Summary vs.
- Net sales increased 20% to
$193.8 million . - Net income remained flat at
$7.0 million or$1.52 per diluted share. - Adjusted net income (a non-GAAP financial measure defined below) was
$7.0 million or$1.53 per diluted share compared to$10.3 million or$2.26 per diluted share. - Adjusted EBITDA (a non-GAAP financial measure defined below) was
$13.0 million compared to$16.1 million . - Gross billings (a key operational metric defined below) increased 3% to
$625.4 million . Distribution segment gross billings increased 4% to$602.3 million , and Solutions segment gross billings remained flat at$23.1 million .
FY 2025 Summary vs. FY 2024
- Net sales increased 40% to
$652.5 million . - Net income increased 15% to
$21.3 million or$4.64 per diluted share. - Adjusted net income (a non-GAAP financial measure defined below) was
$23.3 million or$5.08 per diluted share compared to$24.0 million or$5.26 per diluted share. - Adjusted EBITDA (a non-GAAP financial measure defined below) increased 8% to
$42.9 million . - Gross billings (a key operational metric defined below) increased 18% to
$2.1 billion . Distribution segment gross billings increased 19% to$2.0 billion and Solutions segment gross billings increased 1% to$90.3 million .
Management Commentary
“2025 was another exceptional year for Climb, highlighted by record results across all key financial metrics,” said CEO
“As announced earlier this week, we strengthened our European operations through the acquisition of Interworks, enhancing our Microsoft relationship and expanding our presence to
“Looking ahead, we remain focused on driving sustainable organic growth while maintaining the financial flexibility to support our long-term priorities. As part of this disciplined capital allocation approach, Climb’s Board of Directors determined to suspend the quarterly dividend to preserve financial flexibility and prioritize capital allocation objectives. We will also continue to evaluate M&A opportunities that can strengthen our vendor portfolio and expand our geographic footprint. We believe these initiatives, coupled with our disciplined execution and strong balance sheet, will enable us to deliver on our organic and inorganic growth objectives in 2026.”
Dividend
Climb’s Board of Directors has determined to suspend quarterly cash dividends on its common stock beginning with the first quarter of 2026 to preserve financial flexibility and prioritize the Company’s capital allocation objectives, including funding organic growth initiatives and evaluating strategic opportunities. Based on the Company’s strong return on equity, the Company plans to reinvest the capital for higher growth initiatives.
The Company last declared a quarterly cash dividend on
Fourth Quarter 2025 Financial Results
Net sales in the fourth quarter of 2025 increased 20% to
Gross profit in the fourth quarter of 2025 was
Selling, general, and administrative (“SG&A”) expenses in the fourth quarter of 2025 were
Net income in the fourth quarter of 2025 remained flat at
Adjusted EBITDA in the fourth quarter of 2025 was
On
For more information on the non-GAAP financial measures discussed in this press release, please see the section titled, “Non-GAAP Financial Measures,” and the reconciliations of non-GAAP financial measures to their nearest comparable GAAP financial measures at the end of this press release.
Conference Call
The Company will conduct a conference call tomorrow,
Climb management will host the conference call, followed by a question-and-answer period.
Date:
Time:
Toll-free dial-in number: (800) 274-8461
International dial-in number: (203) 518-9814
Conference ID: CLIMB
Webcast: Climb’s Q4 & FY 2025 Conference Call
If you have any difficulty registering or connecting with the conference call, please contact Elevate IR at (720) 330-2829.
The conference call will also be available for replay on the investor relations section of the Company’s website at www.climbglobalsolutions.com.
About Climb Global Solutions
Climb
Additional information can be found by visiting www.climbglobalsolutions.com.
Non-GAAP Financial Measures
Climb
Key Operational Metric
Gross Billings
Gross billings are the total dollar value of customer purchases of goods and services during the period, net of customer returns and credit memos, sales, or other taxes. Gross billings include the transaction values for certain sales transactions that are recognized on a net basis, and, therefore, includes amounts that will not be recognized as revenue. We use gross billings as an operational metric to assess the volume of transactions or market share for our business as well as to understand changes in our accounts receivable and accounts payable. We believe gross billings will aid investors in the same manner.
Forward-Looking Statements
The statements in this release, other than statements of historical fact, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and are intended to come within the safe harbor protection provided by those sections. These forward-looking statements are subject to certain risks and uncertainties. Many of the forward-looking statements may be identified by words such as “looking ahead,” “believes,” “expects,” “intends,” “anticipates,” “plans,” “estimates,” “projects,” “forecasts,” “should,” “could,” “would,” “will,” “confident,” “may,” “can,” “potential,” “possible,” “proposed,” “in process,” “under construction,” “in development,” “opportunity,” “target,” “outlook,” “maintain,” “continue,” “goal,” “aim,” “commit,” or similar expressions, or when we discuss our priorities, strategy, goals, vision, mission, opportunities, projections, intentions or expectations. In this press release, the forward-looking statements relate to, among other things, declaring and reaffirming our strategic goals, future operating results, and the effects and potential benefits of strategic acquisitions on our business, payments of dividends and the Company’s capital allocation objectives. Factors, among others, that could cause actual results and events to differ materially from those described in any forward-looking statements include, without limitation, our ability to recognize the anticipated benefits of the acquisitions of
Company Contact
Chief Financial Officer
(732) 847-2451
MatthewS@ClimbCS.com
Investor Relations Contact
Elevate IR
(720) 330-2829
CLMB@elevate-ir.com
| CLIMB | |||||||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | |||||||||
| (Unaudited) | |||||||||
| (Amounts in thousands, except share and per share amounts) | |||||||||
| ASSETS | |||||||||
| Current assets | |||||||||
| Cash and cash equivalents | $ | 36,563 | $ | 29,778 | |||||
| Accounts receivable, net of allowance for expected credit losses of | 324,345 | 341,597 | |||||||
| Inventory, net | 2,502 | 2,447 | |||||||
| Prepaid expenses and other current assets | 10,825 | 6,874 | |||||||
| Total current assets | 374,235 | 380,696 | |||||||
| Equipment and leasehold improvements, net | 13,339 | 12,853 | |||||||
| 36,838 | 34,924 | ||||||||
| Other intangibles, net | 32,228 | 36,550 | |||||||
| Right-of-use assets, net | 1,717 | 1,965 | |||||||
| Accounts receivable long-term, net | 1,233 | 1,174 | |||||||
| Other assets | 510 | 824 | |||||||
| Deferred income tax assets | 133 | 193 | |||||||
| Total assets | $ | 460,233 | $ | 469,179 | |||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||
| Current liabilities | |||||||||
| Accounts payable and accrued expenses | $ | 336,505 | $ | 370,397 | |||||
| Lease liability, current portion | 791 | 654 | |||||||
| Term loan, current portion | 191 | 560 | |||||||
| Total current liabilities | 337,487 | 371,611 | |||||||
| Lease liability, net of current portion | 1,216 | 1,685 | |||||||
| Deferred income tax liabilities | 4,923 | 4,723 | |||||||
| Term loan, net of current portion | – | 191 | |||||||
| Non-current liabilities | 28 | 381 | |||||||
| Total liabilities | 343,654 | 378,591 | |||||||
| Stockholders' equity | |||||||||
| Common stock, | |||||||||
| issued, and 4,610,618 and 4,601,302 shares outstanding, respectively | 53 | 53 | |||||||
| Additional paid-in capital | 42,338 | 37,977 | |||||||
| (14,909 | ) | (13,337 | ) | ||||||
| Retained earnings | 87,039 | 68,787 | |||||||
| Accumulated other comprehensive gain (loss) | 2,058 | (2,892 | ) | ||||||
| Total stockholders' equity | 116,579 | 90,588 | |||||||
| Total liabilities and stockholders' equity | $ | 460,233 | $ | 469,179 | |||||
| CLIMB | |||||||||||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS | |||||||||||||||||
| (Unaudited) | |||||||||||||||||
| (Amounts in thousands, except per share data) | |||||||||||||||||
| Year ended | Three months ended | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||
| $ | 652,517 | $ | 465,607 | $ | 193,845 | $ | 161,760 | ||||||||||
| Cost of sales | 547,247 | 374,527 | 164,013 | 130,513 | |||||||||||||
| Gross profit | 105,270 | 91,080 | 29,832 | 31,247 | |||||||||||||
| Selling, general and administrative expenses | 67,550 | 56,508 | 18,211 | 17,075 | |||||||||||||
| Depreciation & amortization expense | 7,728 | 4,269 | 2,032 | 1,336 | |||||||||||||
| Acquisition related costs | 807 | 2,311 | 74 | 1,110 | |||||||||||||
| Total selling, general and administrative expenses | 76,085 | 63,088 | 20,317 | 19,521 | |||||||||||||
| Income from operations | 29,185 | 27,992 | 9,515 | 11,726 | |||||||||||||
| Interest, net | 844 | 917 | 282 | 162 | |||||||||||||
| Foreign currency transaction (loss) gain | (737 | ) | (273 | ) | (171 | ) | 415 | ||||||||||
| Change in fair value of acquisition contingent consideration | (1,374 | ) | (3,618 | ) | – | (2,466 | ) | ||||||||||
| Income before provision for income taxes | 27,918 | 25,018 | 9,626 | 9,837 | |||||||||||||
| Provision for income taxes | 6,588 | 6,408 | 2,643 | 2,847 | |||||||||||||
| Net income | $ | 21,330 | $ | 18,610 | $ | 6,983 | $ | 6,990 | |||||||||
| Income per common share – Basic | $ | 4.64 | $ | 4.06 | $ | 1.52 | $ | 1.52 | |||||||||
| Income per common share – Diluted | $ | 4.64 | $ | 4.06 | $ | 1.52 | $ | 1.52 | |||||||||
| Weighted average common shares outstanding – Basic | 4,524 | 4,465 | 4,542 | 4,485 | |||||||||||||
| Weighted average common shares outstanding – Diluted | 4,524 | 4,465 | 4,542 | 4,485 | |||||||||||||
| Dividends paid per common share | $ | 0.68 | $ | 0.68 | $ | 0.17 | $ | 0.17 | |||||||||
| Reconciliation of GAAP and Non-GAAP Financial Measures and Key Operational Metrics (unaudited) | |||||||||||||||||
| (Amounts in thousands, except per share data) | |||||||||||||||||
| The table below presents net income reconciled to adjusted EBITDA (Non-GAAP) (1): | |||||||||||||||||
| Year ended | Three months ended | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||
| Net income | $ | 21,330 | $ | 18,610 | $ | 6,983 | $ | 6,990 | |||||||||
| Provision for income taxes | 6,588 | 6,408 | 2,643 | 2,847 | |||||||||||||
| Depreciation and amortization | 7,728 | 4,269 | 2,032 | 1,336 | |||||||||||||
| Interest expense | 293 | 335 | 67 | 69 | |||||||||||||
| EBITDA | 35,939 | 29,622 | 11,725 | 11,242 | |||||||||||||
| Share-based compensation | 4,775 | 4,070 | 1,201 | 1,260 | |||||||||||||
| Acquisition related costs | 807 | 2,311 | 74 | 1,110 | |||||||||||||
| Change in fair value of acquisition contingent consideration | 1,374 | 3,618 | – | 2,466 | |||||||||||||
| Adjusted EBITDA | $ | 42,895 | $ | 39,621 | $ | 13,000 | $ | 16,078 | |||||||||
| Year ended | Three months ended | ||||||||||||||||
| Components of interest, net | 2025 | 2024 | 2025 | 2024 | |||||||||||||
| Amortization of discount on accounts receivable with extended payment terms | $ | (67 | ) | $ | (34 | ) | $ | (33 | ) | $ | (11 | ) | |||||
| Interest income | (1,070 | ) | (1,218 | ) | (316 | ) | (220 | ) | |||||||||
| Interest expense | 293 | 335 | 67 | 69 | |||||||||||||
| Interest, net | $ | (844 | ) | $ | (917 | ) | $ | (282 | ) | $ | (162 | ) | |||||
| (1) We define adjusted EBITDA, as net income, plus provision for income taxes, depreciation, amortization, share-based compensation, interest, acquisition related costs and change in fair value of acquisition contingent consideration. We define effective margin as adjusted EBITDA as a percentage of gross profit. We provided a reconciliation of adjusted EBITDA to net income, which is the most directly comparable US GAAP measure. We use adjusted EBITDA as a supplemental measure of our performance to gain insight into our businesses profitability, operating performance and performance trends, and to provide management and investors a useful measure for period-to-period comparisons by excluding items that management believes are not reflective of our underlying operating performance. Accordingly, we believe that Adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results. Adjusted EBITDA is also a component to our financial covenants in our credit facility. Our use of adjusted EBITDA has limitations, and you should not consider it in isolation or as a substitute for analysis of our financial results as reported under US GAAP. In addition, other companies, including companies in our industry, might calculate adjusted EBITDA, or similarly titled measures differently, which may reduce their usefulness as comparative measures. | |||||||||||||||||
| The table below presents net income reconciled to adjusted net income (Non-GAAP) (2): | |||||||||||||||||
| Year ended | Three months ended | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||
| Net income | $ | 21,330 | $ | 18,610 | $ | 6,983 | $ | 6,990 | |||||||||
| Acquisition related costs, net of income taxes | 605 | 1,733 | 56 | 833 | |||||||||||||
| Change in fair value of acquisition contingent consideration | 1,374 | 3,618 | – | 2,466 | |||||||||||||
| Adjusted net income | $ | 23,309 | $ | 23,961 | $ | 7,039 | $ | 10,289 | |||||||||
| Adjusted net income per common share – diluted | $ | 5.08 | $ | 5.26 | $ | 1.53 | $ | 2.26 | |||||||||
| (2) We define adjusted net income as net income excluding acquisition related costs, net of income taxes and the change in fair value of acquisition contingent consideration. We provided a reconciliation of adjusted net income to net income, which is the most directly comparable | |||||||||||||||||
| The table below presents the operational metric of gross billings by segment (3): | |||||||||||||||||
| Year ended | Three months ended | ||||||||||||||||
| 2025 | 2024 | 2025 | 2024 | ||||||||||||||
| Distribution gross billings | $ | 2,014,847 | $ | 1,695,538 | $ | 602,345 | $ | 581,963 | |||||||||
| Solutions gross billings | 90,321 | 89,764 | 23,073 | 23,045 | |||||||||||||
| Total gross billings | $ | 2,105,168 | $ | 1,785,302 | $ | 625,418 | $ | 605,008 | |||||||||
| (3) Gross billings are the total dollar value of customer purchases of goods and services during the period, net of customer returns and credit memos, sales, or other taxes. Gross billings include the transaction values for certain sales transactions that are recognized on a net basis, and, therefore, include amounts that will not be recognized as revenue. We use gross billings as an operational metric to assess the volume of transactions or market share for our business as well as to understand changes in our accounts receivable and accounts payable. We believe gross billings will aid investors in the same manner. | |||||||||||||||||
Source: